Sign inGet started

Celniker Abbie

Insider CIK 1590250 · EBIO President and CEO, Director · DYAX Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
SESN Sesen Bio, Inc. A Award deriv2018-06-122018-06-1452,500— $052,500SEC↗
EBIO Eleven Biotherapeutics, In A Award deriv2017-05-192017-05-238,072— $08,072SEC↗
EBIO Eleven Biotherapeutics, In S Sale2016-09-282016-09-3010,031$3.00 $30.1K409,915SEC↗
EBIO Eleven Biotherapeutics, In A Award deriv2016-09-202016-09-2229,988— $090,000SEC↗
EBIO Eleven Biotherapeutics, In A Award deriv2016-07-092016-07-1229,988— $060,012SEC↗
EBIO Eleven Biotherapeutics, In S Sale2016-06-272016-06-2910,029$2.08 $20.9K419,946SEC↗
EBIO Eleven Biotherapeutics, In A Award deriv2016-06-152016-06-1730,024— $030,024SEC↗
EBIO Eleven Biotherapeutics, In A Award deriv2016-02-252016-02-2990,000— $090,000SEC↗
EBIO Eleven Biotherapeutics, In A Award deriv2016-02-252016-02-29113,250— $0113,250SEC↗
DYAX DYAX CORP D To issuer deriv2016-01-222016-01-2250,000— $00SEC↗
EBIO Eleven Biotherapeutics, In S Sale2015-12-282015-12-3010,155$2.85 $28.9K429,975SEC↗
EBIO Eleven Biotherapeutics, In A Award2015-06-262015-06-2985,800— $0440,130SEC↗
DYAX DYAX CORP A Award deriv2015-05-122015-05-1450,000— $050,000SEC↗
EBIO Eleven Biotherapeutics, In A Award deriv2015-02-262015-02-27145,000— $0282,795SEC↗